Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Eastern Cooperative Oncology Group
Radiation Therapy Oncology Group
Academic and Community Cancer Research United
ETOP IBCSG Partners Foundation
National Institute of Oncology, Hungary
INSYS Therapeutics Inc
National Cancer Institute (NCI)
ETOP IBCSG Partners Foundation
SWOG Cancer Research Network